ARTICLE | Clinical News
Retacrit epoetin zeta regulatory update
July 4, 2011 7:00 AM UTC
EMA's CHMP issued a positive opinion to extend the indication for Retacrit epoetin zeta to include the reduction of allogeneic blood transfusions in adult non-iron deficient patients prior to major el...